Denali Therapeutics (DNLI) Shares Outstanding (Diluted) (2018 - 2026)

Denali Therapeutics (DNLI) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Denali Therapeutics 3.90 Bn 3.90 Bn 3.51 Mn 187.31 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 187.31 Mn
Mar 31, 2026 186.64 Mn
Dec 31, 2025 172.65 Mn
Sep 30, 2025 172.42 Mn
Jun 30, 2025 171.45 Mn
Mar 31, 2025 171.22 Mn
Dec 31, 2024 164.47 Mn
Sep 30, 2024 169.46 Mn
Jun 30, 2024 168.83 Mn
Mar 31, 2024 149.40 Mn
Dec 31, 2023 137.37 Mn
Sep 30, 2023 137.64 Mn
Jun 30, 2023 140.93 Mn
Mar 31, 2023 136.52 Mn
Dec 31, 2022 125.53 Mn
Sep 30, 2022 123.47 Mn
Jun 30, 2022 123.01 Mn
Mar 31, 2022 122.67 Mn
Dec 31, 2021 121.52 Mn
Sep 30, 2021 121.74 Mn